Are hs-cTnT levels associated with replacement fibrosis and progressive changes in left ventricular structure in CVD-free adults?
Minor elevations of hs-cTnT may serve as an early biochemical signature of subclinical cardiac disease, providing an opportunity for targeted preventive interventions.
hs-cTnT levels are associated with replacement fibrosis and progressive changes in left ventricular structure in CVD-free adults, findings that may precede HF symptoms by years. Minor elevations of hs-cTnT may represent a biochemical signature of early subclinical cardiac disease, providing an opportunity for targeted preventive interventions.
Seliger et al. (Fri,) studied this question.